Corcept Therapeutics | CORT - Des Atouts





Des Atouts Changement Date
Acadia Pharmaceuticals USD 1.74B 137.67M 2026-06
Alaunos Therapeutics USD 1.88M 1.08M 2026-03
ANI Pharmaceuticals USD 1.49B 72.14M 2026-06
Ardelyx USD 504.51M 2.9M 2026-03
Aurora Cannabis CAD 601.09M 174.2M 2026-03
BioMarin Pharmaceutical USD 11.72B 3.13B 2026-06
Bristol-Myers Squibb USD 87.63B 1.16B 2026-06
Canopy Growth CAD 1.12B 12.54M 2026-03
Corcept Therapeutics USD 888.7M 73.82M 2026-06
Eli Lilly USD 142.28B 25.71B 2026-06
J&J USD 201.06B 167M 2026-06
Knight Therapeutics CAD 1.05B 2.28M 2025-12
Lexicon Pharmaceuticals USD 268.82M 83.83M 2026-03
Merck USD 129.8B 1.12B 2026-06
Nektar Therapeutics USD 763.27M 482.86M 2026-03
Novartis USD 122.03B 3.5B 2026-06
Novartis USD 118.53B 7.58B 2026-03
Omeros USD 200.57M 34.59M 2025-06
Pacira USD 1.24B 35.44M 2026-06
Pfizer USD 201.13B 6.49B 2026-06
Supernus Pharmaceuticals USD 1.43B 72.62M 2026-06
TG Therapeutics USD 1.64B 110.79M 2026-06